|
1
|
Liu B, Cheng B, Wang C, Chen P and Cheng
Y: The prognostic significance of metabolic syndrome and weight
loss in esophageal squamous cell carcinoma. Sci Rep.
8(10101)2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Zhang ZY, Xuan Y, Jin XY, Tian X and Wu R:
Meta-analysis demonstrates association of XRCC1 genetic
polymorphism Arg399Gln with esophageal cancer risk in the Chinese
population. Genet Mol Res. 12:2567–2577. 2013.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Yin M, Tan D and Wei Q: Genetic variants
of the XRCC1 gene and susceptibility to esophageal cancer: A
meta-analysis. Int J Clin Exp Med. 2:26–35. 2009.PubMed/NCBI
|
|
4
|
Bosetti C, La Vecchia C, Talamini R,
Simonato L, Zambon P, Negri E, Trichopoulos D, Lagiou P, Bardini R
and Franceschi S: Food groups and risk of squamous cell esophageal
cancer in northern Italy. Int J Cancer. 87:289–294. 2000.PubMed/NCBI
|
|
5
|
Talamini G, Capelli P, Zamboni G,
Mastromauro M, Pasetto M, Castagnini A, Angelini G, Bassi C and
Scarpa A: Alcohol, smoking and papillomavirus infection as risk
factors for esophageal squamous-cell papilloma and esophageal
squamous-cell carcinoma in Italy. Int J Cancer. 86:874–878.
2000.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Hao B, Wang H, Zhou K, Li Y, Chen X, Zhou
G, Zhu Y, Miao X, Tan W, Wei Q, et al: Identification of genetic
variants in base excision repair pathway and their associations
with risk of esophageal squamous cell carcinoma. Cancer Res.
64:4378–4384. 2004.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Li WQ, Hu N, Hyland PL, Gao Y, Wang ZM, Yu
K, Su H, Wang CY, Wang LM, Chanock SJ, et al: Genetic variants in
DNA repair pathway genes and risk of esophageal squamous cell
carcinoma and gastric adenocarcinoma in a Chinese population.
Carcinogenesis. 34:1536–1542. 2013.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Yang X, Zhu H, Qin Q, Yang Y, Yang Y,
Cheng H and Sun X: Genetic variants and risk of esophageal squamous
cell carcinoma: A GWAS-based pathway analysis. Gene. 556:149–152.
2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Wang Z, Gan L, Nie W and Geng Y: The OGG1
Ser326Cys polymorphism and the risk of esophageal cancer: A
meta-analysis. Genet Test Mol Biomarkers. 17:780–785.
2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Dai ZJ, Shao YP, Kang HF, Tang W, Xu D,
Zhao Y, Liu D, Wang M, Yang PT and Wang XJ: Relationship between
apurinic endonuclease 1 Asp148Glu polymorphism and gastrointestinal
cancer risk: An updated meta-analysis. World J Gastroenterol.
21:5081–5089. 2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Li S, Deng Y, You JP, Chen ZP, Peng QL,
Huang XM, Lu QH, Huang XL, Zhao JM and Qin X: XRCC1 Arg399Gln,
Arg194Trp, and Arg280His polymorphisms in esophageal cancer risk: A
meta-analysis. Dig Dis Sci. 58:1880–1890. 2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Dai L, Wang K, Zhang J, Lv Q, Wu X and
Wang Y: XRCC1 gene polymorphisms and esophageal squamous cell
carcinoma risk in Chinese population: A meta-analysis of
case-control studies. Int J Cancer. 125:1102–1109. 2009.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Yun YX, Dai LP, Wang P, Wang KJ, Zhang JY
and Xie W: Association of polymorphisms in X-ray repair cross
complementing 1 gene and risk of esophageal squamous cell carcinoma
in a Chinese population. Biomed Res Int.
2015(509215)2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Upadhyay R, Malik MA, Zargar SA and Mittal
B: OGG1 Ser326Cys polymorphism and susceptibility to esophageal
cancer in low and high at-risk populations of Northern India. J
Gastrointest Cancer. 41:110–115. 2010.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Tse D, Zhai R, Zhou W, Heist RS, Asomaning
K, Su L, Lynch TJ, Wain JC, Christiani DC and Liu G: Polymorphisms
of the NER pathway genes, ERCC1 and XPD are associated with
esophageal adenocarcinoma risk. Cancer Causes Control.
19:1077–1083. 2008.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Liu GC, Zhou YF, Su XC and Zhang J:
Interaction between TP53 and XRCC1 increases susceptibility to
cervical cancer development: A case control study. BMC Cancer.
19(24)2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Nanda SS, Gandhi AK, Rastogi M, Khurana R,
Hadi R, Sahni K, Mishra SP, Srivastava AK, Bhatt MLB and Parmar D:
Evaluation of XRCC1 gene polymorphism as a biomarker in head and
neck cancer patients undergoing chemoradiation therapy. Int J
Radiat Oncol Biol Phys. 101:593–601. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Liu R, Yin LH and Pu YP: Reduced
expression of human DNA repair genes in esophageal squamous-cell
carcinoma in china. J Toxicol Environ Health A. 70:956–963.
2007.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Cai L, You NC, Lu H, Mu LN, Lu QY, Yu SZ,
Le AD, Marshall J, Heber D and Zhang ZF: Dietary selenium intake,
aldehyde dehydrogenase-2 and X-ray repair cross-complementing 1
genetic polymorphisms, and the risk of esophageal squamous cell
carcinoma. Cancer. 106:2345–2354. 2006.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Li M, Yu X, Zhang ZY, Wu CL and Xu HL:
Interaction of XRCC1 Arg399Gln polymorphism and alcohol consumption
influences susceptibility of esophageal cancer. Gastroenterol Res
Pract. 2016(9495417)2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Djansugurova LB, Perfilyeva AV, Zhunusova
GS, Djantaeva KB, Iksan OA and Khussainova EM: The determination of
genetic markers of age-related cancer pathologies in populations
from Kazakhstan. Front Genet. 4(70)2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Hamajima N, Saito T, Matsuo K and Tajima
K: Competitive amplification and unspecific amplification in
polymerase chain reaction with confronting two-pair primers. J Mol
Diagn. 4:103–107. 2002.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Yin J, Vogel U, Ma Y, Qi R and Wang H:
Haplotypes of nine single nucleotide polymorphisms on chromosome
19q13.2-3 associated with susceptibility of lung cancer in a
Chinese population. Mutat Res. 641:12–18. 2008.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Xing D, Qi J, Miao X, Lu W, Tan W and Lin
D: Polymorphisms of DNA repair genes XRCC1 and XPD and their
associations with risk of esophageal squamous cell carcinoma in a
Chinese population. Int J Cancer. 100:600–605. 2002.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Xiong Y, Zhang Q, Ye J, Pan S and Ge L:
Associations between three XRCC1 polymorphisms and hepatocellular
carcinoma risk: A meta-analysis of case-control studies. PLoS One.
13(e0206853)2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Pan JL, Gao J, Hou JH, Hu DZ and Li L:
Interaction between environmental risk factors and
catechol-O-methyltransferase (COMT) and X-Ray repair
cross-complementing protein 1 (XRCC1) gene polymorphisms in risk of
lung cancer among non-smoking Chinese women: A case-control study.
Med Sci Monit. 24:5689–5697. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Lin J, Ye Q, Wang Y, Wang Y and Zeng Y:
Association between XRCC1 single-nucleotide polymorphisms and
susceptibility to nasopharyngeal carcinoma: An update
meta-analysis. Medicine (Baltimore). 97(e11852)2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Bashir K, Sarwar R, Fatima S, Saeed S,
Mahjabeen I and Akhtar Kayani M: Haplotype analysis of XRCC1 gene
polymorphisms and the risk of thyroid carcinoma. J BUON.
23:234–243. 2018.PubMed/NCBI
|
|
30
|
Feki-Tounsi M, Khlifi R, Louati I, Fourati
M, Mhiri MN, Hamza-Chaffai A and Rebai A: Polymorphisms in XRCC1,
ERCC2, and ERCC3 DNA repair genes, CYP1A1 xenobiotic metabolism
gene, and tobacco are associated with bladder cancer susceptibility
in Tunisian population. Environ Sci Pollut Res Int. 24:22476–22484.
2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Fouad H, Sabry D, Morsi H, Shehab H and
Abuzaid NF: XRCC1 Gene polymorphisms and miR-21 expression in
patients with colorectal carcinoma. Eurasian J Med. 49:132–136.
2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Chen S, Zhu XC, Liu YL, Wang C and Zhang
KG: Investigating the association between XRCC1 gene polymorphisms
and susceptibility to gastric cancer. Genet Mol Res.
15:2016.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Zhai XD, Mo YN, Xue XQ, Zhao GS, Gao LB,
Ai HW and Ye Y: XRCC1 codon 280 and ERCC2 codon 751 polymorphisms
and risk of esophageal squamous cell carcinoma in a Chinese
population. Bull Cancer. 96:E61–E65. 2009.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Moser J, Kool H, Giakzidis I, Caldecott K,
Mullenders LH and Fousteri MI: Sealing of chromosomal DNA nicks
during nucleotide excision repair requires XRCC1 and DNA ligase III
alpha in a cell-cycle-specific manner. Mol Cell. 27:311–323.
2007.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Tomkinson AE, Naila T and Khattri Bhandari
S: Altered DNA ligase activity in human disease. Mutagenesis.
35:51–60. 2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Wang R, Hao W, Pan L, Boldogh I and Ba X:
The roles of base excision repair enzyme OGG1 in gene expression.
Cell Mol Life Sci. 75:3741–3750. 2018.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Ba X and Boldogh I: 8-Oxoguanine DNA
glycosylase 1: Beyond repair of the oxidatively modified base
lesions. Redox Biol. 14:669–678. 2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Fleming AM and Burrows CJ:
8-Oxo-7,8-dihydroguanine, friend and foe: Epigenetic-like regulator
versus initiator of mutagenesis. DNA Repair (Amst). 56:75–83.
2017.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Wei B, Zhou Y, Xu Z, Xi B, Cheng H, Ruan
J, Zhu M, Hu Q, Wang Q, Wang Z, et al: The effect of hOGG1
Ser326Cys polymorphism on cancer risk: Evidence from a
meta-analysis. PLoS One. 6(e27545)2011.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Zou H, Li Q, Xia W, Liu Y, Wei X and Wang
D: Association between the OGG1 Ser326Cys polymorphism and cancer
risk: Evidence from 152 case-control studies. J Cancer.
7:1273–1280. 2016.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Peng Q, Lu Y, Lao X, Chen Z, Li R, Sui J,
Qin X and Li S: Association between OGG1 Ser326Cys and APEX1
Asp148Glu polymorphisms and breast cancer risk: A meta-analysis.
Diagn Pathol. 9(108)2014.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Li M and Wilson DM III: Human
apurinic/apyrimidinic endonuclease 1. Antioxid Redox Signal.
20:678–707. 2014.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Dai ZJ, Wang XJ, Kang AJ, Ma XB, Min WL,
Lin S, Zhao Y, Yang PT, Wang M and Kang HF: Association between
APE1 single nucleotide polymorphism (rs1760944) and cancer risk: A
meta-analysis based on 6,419 cancer cases and 6,781 case-free
controls. J Cancer. 5:253–259. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
44
|
Zhou B, Shan H, Su Y, Xia K, Shao X, Mao W
and Shao Q: The association of APE1-656T>G and 1349 T>G
polymorphisms and cancer risk: A meta-analysis based on 37
case-control studies. BMC Cancer. 11(521)2011.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Zhong JH, Zhao Z, Liu J, Yu HL, Zhou JY
and Shi R: Association between APE1 Asp148Glu polymorphism and the
risk of urinary cancers: A meta-analysis of 18 case-control
studies. Onco Targets Ther. 9:1499–1510. 2016.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Li H, Zou J, Mi J, Wei X, Zhao D, Zhang S
and Tian G: Association of APE1 Gene Asp148Glu variant with
digestive cancer: A meta-analysis. Med Sci Monit. 21:2456–2466.
2015.PubMed/NCBI View Article : Google Scholar
|
